Equities

MedCap AB (publ)

MedCap AB (publ)

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)563.00
  • Today's Change20.00 / 3.68%
  • Shares traded9.15k
  • 1 Year change+83.09%
  • Beta0.7161
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

  • Revenue in SEK (TTM)1.79bn
  • Net income in SEK227.90m
  • Incorporated2001
  • Employees534.00
  • Location
    MedCap AB (publ)Engelbrektsgatan 9-1STOCKHOLM 114 32SwedenSWE
  • Phone+46 8347110
  • Websitehttps://www.medcap.se/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Linc AB1.57bn1.58bn4.34bn2.002.750.9402--2.7727.3027.3027.1279.770.4099--78.95785,230,500.0041.269.7641.299.76----100.6898.02----0.00--173.9116.70185.6414.42----
Investment Oresund AB920.77m937.24m5.10bn6.005.441.06--5.5420.6220.6220.26105.900.1959----153,461,800.0019.940.415720.760.4202----101.7852.79----0.00661,224.91115.74-13.99114.71-12.9831.064.94
Treasure ASA-214.25m387.04m5.66bn0.0014.510.7636----1.911.91-1.0536.23-0.0298------5.3810.765.3810.76------887.92----0.00262.19-----15.28----26.72
Svolder AB895.30m876.20m5.69bn6.006.230.9192--6.358.688.688.7358.800.1585--157.07149,216,700.0015.5112.5815.5512.6396.9397.8797.8796.09----0.0014.64283.16138.51266.74--0.0025.90
eQ Oyj813.86m343.86m6.09bn104.0017.627.7617.047.490.72060.72061.711.640.7207--119.17695,524.8030.4531.0734.3337.8198.8299.2542.2544.88----0.0587102.65-8.679.36-13.2112.11-25.338.18
Creades publ AB2.17bn2.10bn6.42bn8.004.450.9489--2.9615.4915.4916.0172.720.2396--149.86310,428,600.0023.1913.1523.5413.38----96.7893.42----0.001112.58112.11-16.86114.131.03--2.71
MedCap AB (publ)1.79bn227.90m8.04bn534.0035.546.7423.634.4915.2815.28119.9280.581.023.586.303,758,614.0013.109.0116.1612.0046.6346.7712.809.841.8343.340.22480.0042.8417.4946.4347.822.82--
Ratos AB32.35bn958.00m10.56bn11.05k10.900.84192.460.32632.892.8998.4637.370.92029.245.902,926,814.005.083.397.585.1143.2640.225.524.060.73461.320.398844.7112.967.85122.26---15.0120.11
Data as of Nov 22 2024. Currency figures normalised to MedCap AB (publ)'s reporting currency: Swedish Krona SEK

Institutional shareholders

42.49%Per cent of shares held by top holders
HolderShares% Held
Lannebo Fonder ABas of 31 Aug 20241.27m8.59%
Spiltan Fonder ABas of 31 Dec 20231.27m8.59%
Swedbank Robur Fonder ABas of 24 Jul 2024796.79k5.38%
Alcur Fonder ABas of 31 Dec 2023567.62k3.83%
Nordea Investment Management ABas of 31 Jul 2024540.74k3.65%
ODIN Forvaltning AS (Sweden)as of 31 Dec 2023500.00k3.38%
Andra AP-fondenas of 31 Dec 2023476.77k3.22%
Handelsbanken Fonder ABas of 31 Oct 2024340.65k2.30%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 29 Sep 2023267.59k1.81%
L�nsf�rs�kringar Fondf�rvaltning ABas of 31 Oct 2024256.50k1.73%
More ▼
Data from 30 Aug 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.